CRIT REV ONCOL HEMAT 润色咨询

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

出版年份:1983 年文章数:1913 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=b37f681, cover=https://img.medsci.cn/images/journal/cover/2021/HEj_202109271314479880.jpg, fullname=CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, abbr=CRIT REV ONCOL HEMAT, pyear=1983, frequence=Monthly, articleNumbers=1913, citedSelf2015=1.8, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均4.83月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1040-8428, greenSci=https://www.greensci.net/search?kw=1040-8428, scijournal=https://www.scijournal.org/impact-factor-of-CRIT-REV-ONCOL-HEMAT.shtml, medsciHotlightString=null, medsciHotlightRealtime=6.99, medsciHotlight=7.506, medsciHotlight5year=5.04441, citescore=0.0, hIndex=122, impactFactor=6.2, orgnization=Elsevier Ireland Ltd, orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=http://www.croh-online.com/, websiteHits=7516, guideForAuthor=https://www.elsevier.com/journals/critical-reviews-in-oncology-hematology/1040-8428/guide-for-authors, guideForAuthorHits=397, submitWebsite=https://ees.elsevier.com/croh, submitWebsiteHits=1897, content=Critical Reviews in Oncology / Hematology publishes scholarly, critical reviews in all fields of oncology and hematology, and reviews and original research articles in the field of geriatric oncology. Most of the reviews are written on invitation. All reviews and original research articles are subject to peer review before final acceptance. Authors who wish to submit reviews to the Journal are requested to submit a short synopsis of their chosen subject to the Editor, and to indicate the deadline by which they expect to submit their final manuscript. Authors of original research articles are requested to submit their manuscripts directly to the Editor. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guidelines for Authors., totalCites=11865, brief=CRIT REV ONCOL HEMAT杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=血液学" >血液学</a></strong>”子行业的优秀级杂志, articleType=本刊可能只接收综述类文章或很多文章不被WOS收录, medsciHeat=黑红, medsciComment=CRIT REV ONCOL HEMAT在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=b37f681'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=5), ImpactFactorTagDto(id=3203, tagName=血液肿瘤, createdHits=3), ImpactFactorTagDto(id=3184, tagName=综述, createdHits=3), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=2), ImpactFactorTagDto(id=44095, tagName=review, createdHits=2), ImpactFactorTagDto(id=706, tagName=血液学, createdHits=1), ImpactFactorTagDto(id=5424, tagName=实体肿瘤, createdHits=1), ImpactFactorTagDto(id=438, tagName=胃癌, createdHits=1), ImpactFactorTagDto(id=10874, tagName=药理, createdHits=1), ImpactFactorTagDto(id=4273, tagName=血液, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=4.95), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.74), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.96), GetImpactFactorCiteScoreListResponse(year=2019, citescore=10.1), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=5.628), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=5.778), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=6.635), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=10.073), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=6.99)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Geriatrics and Gerontology , rank=2/93), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Hematology , rank=7/122), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=42/321)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1040-8428[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY[ta], article_number=172, article_number_cn=20, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CRIT REV ONCOL HEMAT/CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
ISSN
1040-8428
影响指数话题
预警等级
MedSci期刊指数
6.99 (MedSci实时期刊指数) | 5.04441 (5年期刊指数)
CiteScore值
0.0
h-index
122
h5-median
暂无数据
出版社/管理机构
杂志由 Elsevier Ireland Ltd 出版或管理
出版国家/地区
Netherlands 荷兰
出版周期
Monthly
出版年份
1983
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|BIOSIS Previews|BIOSIS Reviews Reports And Meetings
JCR分区
暂无数据
中科院分区
大类:医学 2区
小类:医学 2 区